Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy.

Biomedicines · 2022 · PMC9220000 · PMID 35740382

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

No difference in plasma concentration of C2, C3, C5, and MBL was observed between corticosteroid-naïve and -treated AChR-MG patients, and no correlation was found between the protein concentrations and the duration of IS treatment (data not shown), with the exception of MBL levels, that showed a trend to be higher in corticosteroid-naïve than corticosteroid-treated patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.